For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Dermavant Sciences Gmbh

USPTO Granted Patents = 20

EPO Patents = 2

Trademarks = 11

Forward Citations = 34

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Sujatha Sonti (6 out of 13 patents)

Jon Lenn (6 out of 7 patents)

Joey Roger Thomas (6 out of 6 patents)

4. Leandro Santos (6 out of 6 patents)

5. Justin Whiteman (6 out of 6 patents)

6. Michael Quinn Doherty (6 out of 7 patents)

7. Mary Bedard (6 out of 6 patents)

8. Piyush Jain (6 out of 6 patents)

9. Susan H Smith (5 out of 5 patents)

10. Channa K Jayawickreme (4 out of 4 patents)

11. Cunyu Zhang (4 out of 4 patents)

12. William Zuercher (4 out of 4 patents)

13. Ian Paul Andrews (4 out of 4 patents)

14. Nicholas Calandra (4 out of 4 patents)

15. Tyler Andrew Davis (4 out of 5 patents)

20 patents: Sort by Forward Citations

1. 12275696 - Process for preparing tapinarof (2025-04-14),

2. 12252471 - Isoquinoline compounds and their use in treating AhR imbalance (2025-03-18),

3. 11938099 - Use of tapinarof for the treatment of atopic dermatitis (2024-03-26),

4. 11827605 - Isoquinoline compounds and their use in treating AhR imbalance (2023-11-28),

5. 11622945 - Topical pharmaceutical compositions (2023-04-11),

6. 11617724 - Topical pharmaceutical compositions (2023-04-04),

7. 11612573 - Topical pharmaceutical compositions (2023-03-28),

8. 11597692 - Process for preparing tapinarof (2023-03-07),

9. 11590088 - Use of Tapinarof for the treatment of chronic plaque psoriasis (2023-02-28),

10. 11548853 - Isoquinoline compounds and their use in treating AhR imbalance (2023-01-10),

11. 11497718 - Use of tapinarof for the treatment of atopic dermatitis (2022-11-15),

12. 11458108 - Topical pharmaceutical compositions (2022-10-04),

13. 11267788 - Isoquinoline compounds and their use in treating AhR imbalance (2022-03-08),

14. 10961175 - Process for preparing tapinarof (2021-03-30),

15. 10647649 - Process for preparing tapinarof (2020-05-12),

Dermavant Sciences GmbH is a biopharmaceutical company dedicated to developing innovative therapies for dermatological conditions. They focus on delivering safe and effective treatments for patients with significant unmet medical needs. With a strong emphasis on research and development, Dermavant Sciences GmbH aims to improve the lives of individuals living with skin disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

20 Patents

#24 in Basel

#596 in Switzerland

#30,350 in the World

Basel, Switzerland

Dermavant Sciences Gmbh

Forward Citations = 34

23 inventors:

Sujatha Sonti (6 out of 13 patents)

Jon Lenn (6 out of 7 patents)

Joey Roger Thomas (6 out of 6 patents)

4. Leandro Santos (6 out of 6 patents)

5. Justin Whiteman (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…